Aurinia Pharmaceuticals (AUPH) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Aurinia Pharmaceuticals Inc. has filed a current report with the SEC, indicating routine corporate updates. The report provides details such as the company’s address, contact information, and confirmation of its common shares being traded on The Nasdaq Stock Market under the symbol AUPH.
For further insights into AUPH stock, check out TipRanks’ Stock Analysis page.